Building Asia’s Most Trusted Cannabis Innovation Ecosystem

Bicaro Holding

A fully licensed medical cannabis group in Thailand, specializing in advanced indoor cultivation, regulated outdoor farming,
and biotechnology-driven production — built for sustainable, long-term investor growth.

Thailand’s Licensed Leader
in
Medical Cannabis

Advancing indoor cultivation, CBD farming, and cannabis biotechnology in Asia.

Bicaro Holding Co., Ltd. is a fully licensed medical cannabis company in Thailand specializing in advanced indoor smart-cultivation, high-yield outdoor CBD plantations, and biotech-driven product development.
We operate under Thai FDA cultivation approvals and GACP-aligned practices, building a scalable, regulated ecosystem for pharmaceutical-grade cannabis production.

Investment Opportunities

With Thailand opening regulated pathways for medical cannabis, Bicaro offers early access to a high-growth, compliant, and scalable sector. Investors benefit from structured returns, multi-stream revenue models, asset-backed cultivation units, and long-term expansion potential.

Why Thailand Market?

Thailand is the first country in Asia to legalize medical cannabis, creating a unique
early-entry advantage in a rapidly expanding regulated industry.

First-Mover in Asia

Thailand is the first Asian nation to legalize medical cannabis, offering investors a strategic early-entry advantage.

Supportive Regulation

A regulated framework with strong government oversight enables compliant, scalable, and long-term industry growth.

Ideal Cultivation Conditions

Fertile soil, tropical climate, and strong agriculture expertise support high-yield medical and CBD cultivation.

Growing Cannabis Market

The region’s rapid shift toward regulated medical cannabis is accelerating product demand.

Current Projects

Discover our core developments shaping the future of regulated cannabis cultivation,
biotechnology, and sustainable production in Thailand.

Indoor Medical Cannabis Facility

Our licensed, smart-controlled indoor cultivation facility engineered for pharmaceutical-grade cannabis. Using advanced environmental controls and GACP-aligned practices, we ensure consistent quality, purity, and scalable production.

Progress

Outdoor CBD & Hemp Plantation

Large-scale, sustainable outdoor farming zones dedicated to CBD and hemp cultivation. Designed for high-volume production, cost-efficient operations, and diversified raw material supply for wellness, extracts, and manufacturing.

Progress

Biotech & Genetics Research Lab

A growing R&D division focused on strain genetics, cannabinoid research, cultivation optimization, and tissue culture innovations to support future medical-grade, export-ready products with enhanced global standards.

Progress

Upcoming IPO

Bicaro Holding Co., Ltd. is building a strategic long-term pathway toward a future IPO. Our focus is on strengthening core operations, expanding indoor and outdoor production capacity, and developing a scalable, regulation-aligned ecosystem. This disciplined approach positions us for entry into public markets once key operational and compliance milestones are met.

Why Invest in Bicaro Holding

Bicaro Holding is developing a licensed medical cannabis ecosystem in Thailand, built on indoor and outdoor cultivation, biotechnology, and regulated production ;supported by strong compliance foundations and scalable long-term growth potential.

Investment Highlights

Revenue Model

Diversified income across medical, wellness, and experiential segments.

Advanced Cultivation OPERATIONS

Carefully cultivated, top-quality cannabis from Thailand.
Our operations are centered on regulated indoor medical cultivation and outdoor CBD farming, built to meet Thailand’s medical cannabis standards. With controlled-environment technology, optimized growing systems, and strict GACP alignment, we focus on producing high-quality raw materials for medical and pharmaceutical partners.
Our model emphasizes compliance, scalability, and production excellence—strengthening Thailand’s medical cannabis infrastructure and supporting future export readiness.

Cultivation Licenses

We hold official government-issued cannabis cultivation licenses in Thailand, confirming our legal authority
to grow and operate under regulated medical and compliance standards.

Maconha Herb Cannabis Cultivation License

Official approval granted to Maconha Herb Co., Ltd. for cannabis cultivation in Thailand. This license authorizes regulated planting and cultivation under Thai cannabis laws.

Licensed Cannabis Cultivation – Bicaro Holding

Bicaro Holding Co., Ltd. is officially licensed to cultivate cannabis in Thailand, operating legally under approved regulatory standards, with full government oversight, transparency, and compliance.

Global Opportunity

Asia’s Emerging Medical Cannabis Market Asia’s cannabis industry is entering a major growth phase, led by Thailand — the first country in the region to legalize medical cannabis. With regulations opening and medical demand rising, Asia is becoming one of the most attractive regions for long-term cannabis investment.

Key Growth Forces

Strategic Partnerships & MOUs

We collaborate with trusted organizations across healthcare, genetics, and biotechnology to
strengthen product quality, innovation, and regulatory alignment.

Sitec Pharma (EU)

Collaboration for pharmaceutical-grade cannabis development and export-focused opportunities.

Thailand National Charter of Health

Support for medical cannabis innovation aligned with national health initiatives.

CISW International

Cooperation in global wellness strategy, trade networks, and health-sector development.

Hidden Valley Genetics

Access to premium cannabis genetics and cultivation expertise for medical-grade strains.

News & Updates

Stay updated on Bicaro Holding’s latest partnerships, cultivation milestones, and
product innovations as we grow in the global cannabis industry.

Invest in Asia’s Cannabis Future

Be part of Thailand’s emerging regulated cannabis industry.
Partner with a licensed operator developing a scalable, compliant, and future-ready ecosystem.
Position yourself early in Asia’s fastest-growing medical cannabis market.

Scroll to Top